PLRX Stock, Pliant Therapeutics Inc. Information
Stock Information
Get PLRX Alerts
News, Short Squeeze, Breakout and More Instantly...
About Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.